Selected research
Market Structure
Global Anti-Infectives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-Infectives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-Infectives include Astra Zeneca plc, Glaxo SmithKline plc, Novartis, Wockhardt ltd, Pfizer, Roche, Merck, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-Infectives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-Infectives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-Infectives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Infectives market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-Infectives Segment by Company
Astra Zeneca plc
Glaxo SmithKline plc
Novartis
Wockhardt ltd
Pfizer
Roche
Merck
Johnson & Johnson
Sanofi
Anti-Infectives Segment by Type
Antifungal
Antibacterial
Antiviral
Anti-Infectives Segment by Application
Retail Pharmacies
Mail Order Pharmacies
Hospital Pharmacies
Anti-Infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-Infectives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-Infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Antifungal
- Antibacterial
- Antiviral
Applications
- Retail Pharmacies
- Mail Order Pharmacies
- Hospital Pharmacies
Companies covered
- Astra Zeneca plc
- Glaxo SmithKline plc
- Novartis
- Wockhardt ltd
- Pfizer
- Roche
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-Infectives Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-Infectives Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-Infectives Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-Infectives Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-Infectives Market Dynamics
- 2.1 Anti-Infectives Industry Trends
- 2.2 Anti-Infectives Industry Drivers
- 2.3 Anti-Infectives Industry Opportunities and Challenges
- 2.4 Anti-Infectives Industry Restraints
3 Anti-Infectives Market by Manufacturers
- 3.1 Global Anti-Infectives Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-Infectives Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-Infectives Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-Infectives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-Infectives Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-Infectives Manufacturers, Product Type & Application
- 3.7 Global Anti-Infectives Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-Infectives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-Infectives Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-Infectives Tier 1, Tier 2, and Tier 3
4 Anti-Infectives Market by Type
- 4.1 Anti-Infectives Type Introduction
- 4.1.1 Antifungal
- 4.1.2 Antibacterial
- 4.1.3 Antiviral
- 4.2 Global Anti-Infectives Sales by Type
- 4.2.1 Global Anti-Infectives Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-Infectives Sales by Type (2021-2032)
- 4.2.3 Global Anti-Infectives Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-Infectives Revenue by Type
- 4.3.1 Global Anti-Infectives Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-Infectives Revenue by Type (2021-2032)
- 4.3.3 Global Anti-Infectives Revenue Market Share by Type (2021-2032)
5 Anti-Infectives Market by Application
- 5.1 Anti-Infectives Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Mail Order Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Anti-Infectives Sales by Application
- 5.2.1 Global Anti-Infectives Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-Infectives Sales by Application (2021-2032)
- 5.2.3 Global Anti-Infectives Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-Infectives Revenue by Application
- 5.3.1 Global Anti-Infectives Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-Infectives Revenue by Application (2021-2032)
- 5.3.3 Global Anti-Infectives Revenue Market Share by Application (2021-2032)
6 Global Anti-Infectives Sales by Region
- 6.1 Global Anti-Infectives Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-Infectives Sales by Region (2021-2032)
- 6.2.1 Global Anti-Infectives Sales by Region (2021-2026)
- 6.2.2 Global Anti-Infectives Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-Infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-Infectives Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-Infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-Infectives Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-Infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-Infectives Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-Infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-Infectives Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-Infectives Revenue by Region
- 7.1 Global Anti-Infectives Revenue by Region
- 7.1.1 Global Anti-Infectives Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-Infectives Revenue by Region (2021-2026)
- 7.1.3 Global Anti-Infectives Revenue by Region (2027-2032)
- 7.1.4 Global Anti-Infectives Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-Infectives Revenue (2021-2032)
- 7.2.2 North America Anti-Infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-Infectives Revenue (2021-2032)
- 7.3.2 Europe Anti-Infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-Infectives Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-Infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-Infectives Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-Infectives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Astra Zeneca plc
- 8.1.1 Astra Zeneca plc Company Information
- 8.1.2 Astra Zeneca plc Business Overview
- 8.1.3 Astra Zeneca plc Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Astra Zeneca plc Anti-Infectives Product Portfolio
- 8.1.5 Astra Zeneca plc Recent Developments
- 8.2 Glaxo SmithKline plc
- 8.2.1 Glaxo SmithKline plc Company Information
- 8.2.2 Glaxo SmithKline plc Business Overview
- 8.2.3 Glaxo SmithKline plc Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Glaxo SmithKline plc Anti-Infectives Product Portfolio
- 8.2.5 Glaxo SmithKline plc Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis Anti-Infectives Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 Wockhardt ltd
- 8.4.1 Wockhardt ltd Company Information
- 8.4.2 Wockhardt ltd Business Overview
- 8.4.3 Wockhardt ltd Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Wockhardt ltd Anti-Infectives Product Portfolio
- 8.4.5 Wockhardt ltd Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Anti-Infectives Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 Roche
- 8.6.1 Roche Company Information
- 8.6.2 Roche Business Overview
- 8.6.3 Roche Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Roche Anti-Infectives Product Portfolio
- 8.6.5 Roche Recent Developments
- 8.7 Merck
- 8.7.1 Merck Company Information
- 8.7.2 Merck Business Overview
- 8.7.3 Merck Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Merck Anti-Infectives Product Portfolio
- 8.7.5 Merck Recent Developments
- 8.8 Johnson & Johnson
- 8.8.1 Johnson & Johnson Company Information
- 8.8.2 Johnson & Johnson Business Overview
- 8.8.3 Johnson & Johnson Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Johnson & Johnson Anti-Infectives Product Portfolio
- 8.8.5 Johnson & Johnson Recent Developments
- 8.9 Sanofi
- 8.9.1 Sanofi Company Information
- 8.9.2 Sanofi Business Overview
- 8.9.3 Sanofi Anti-Infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sanofi Anti-Infectives Product Portfolio
- 8.9.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-Infectives Value Chain Analysis
- 9.1.1 Anti-Infectives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-Infectives Production Mode & Process
- 9.2 Anti-Infectives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-Infectives Distributors
- 9.2.3 Anti-Infectives Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst